These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21207714)

  • 1. [The effects of intranigral microinjection of substance P on apomorphine-induced rotational behavior in 6-OHDA lesions rats].
    Jiao JJ; Gao DM; Zhuang XY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2001 Nov; 17(4):404. PubMed ID: 21207714
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Yang X; Zhao H; Shi H; Wang X; Zhang S; Zhang Z; Zu J; Zhang W; Shen X; Cui G; Hua F
    Exp Neurol; 2015 Sep; 271():168-74. PubMed ID: 26001615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotatory behavior in rats by intranigral application of substance P and an eledoisin fragment.
    Olpe HR; Koella WP
    Brain Res; 1977 May; 126(3):576-9. PubMed ID: 861742
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioural response to bilateral injections of substance P into the substantia nigra of the rat.
    Kelley AE; Iversen SD
    Brain Res; 1978 Dec; 158(2):474-8. PubMed ID: 709379
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of prolyl-leucyl-glycine amide on drug-induced rotation in lesioned rats.
    Smith JR; Morgan M
    Gen Pharmacol; 1982; 13(3):203-7. PubMed ID: 6124481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural and biochemical effects of substance P injected into the substantia nigra of the rat.
    James TA; Starr MS
    J Pharm Pharmacol; 1977 Mar; 29(3):181-2. PubMed ID: 15087
    [No Abstract]   [Full Text] [Related]  

  • 7. Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats.
    García-Ramírez M; Aceves J; Arias-Montaño JA
    Behav Brain Res; 2004 Oct; 154(2):409-15. PubMed ID: 15313028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
    Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
    FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of recovery in the hemiparkinson rat: drug-induced rotation is inadequate.
    Castañeda E; Fleming S; Paquette MA; Boat K; Moffett J; Stachowiak EK; Bloom DC; Stachowiak MK
    Physiol Behav; 2005 Mar; 84(4):525-35. PubMed ID: 15811387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release.
    Hall ME; Stewart JM
    Pharmacol Biochem Behav; 1992 Jan; 41(1):75-8. PubMed ID: 1371611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelatin nanoparticle-mediated intranasal delivery of substance P protects against 6-hydroxydopamine-induced apoptosis: an in vitro and in vivo study.
    Lu CT; Jin RR; Jiang YN; Lin Q; Yu WZ; Mao KL; Tian FR; Zhao YP; Zhao YZ
    Drug Des Devel Ther; 2015; 9():1955-62. PubMed ID: 25897205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra.
    Sengstock GJ; Olanow CW; Dunn AJ; Barone S; Arendash GW
    Exp Neurol; 1994 Nov; 130(1):82-94. PubMed ID: 7529713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranigral transplants of fetal ventral mesencephalic tissue attenuate D1-agonist-induced rotational behavior.
    Yurek DM
    Exp Neurol; 1997 Jan; 143(1):1-9. PubMed ID: 9000440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese neurotoxic time course is not influenced by L-deprenyl systemic treatment: influence of L-deprenyl in manganese neurotoxic time course.
    Fernandes A; de Oliveira EF; de Rezende IC; Ponzoni S
    Brain Res; 2010 Mar; 1317():277-85. PubMed ID: 20045397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DT-diaphorase potentiates the in vivo neurotoxic effect of intranigral injection of salsolinol in rats.
    Díaz-Véliz G; Mora S; Lungenstrass H; Segura-Aguilar J
    Neurotox Res; 2004; 5(8):629-33. PubMed ID: 15111240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats.
    Castellano JM; Batrynchuk J; Dolbeare K; Verma V; Mann A; Skoblenick KJ; Johnson RL; Mishra RK
    Peptides; 2007 Oct; 28(10):2009-15. PubMed ID: 17766011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.